[From the molecule to the drug: innovation or distribution].
作者信息
Ménard H A
出版信息
Union Med Can. 1993 Jan-Feb;122(1):4.
PMID:8465475
Abstract
摘要
相似文献
1
[From the molecule to the drug: innovation or distribution].
Union Med Can. 1993 Jan-Feb;122(1):4.
2
Drug patent protection: how long is long enough?药品专利保护：多长时间才算足够？
CMAJ. 2001 May 1;164(9):1331.
3
The state of innovation in drug development.药物研发中的创新状况。
Clin Pharmacol Ther. 2008 Feb;83(2):227-30. doi: 10.1038/sj.clpt.6100479.
4
Patents: a threat to innovation?专利：对创新的威胁？
Science. 2010 Jan 1;327(5961):31-2; author reply 32. doi: 10.1126/science.327.5961.31.
5
Realizing two-tiered innovation policy through drug regulation.通过药品监管实现两级创新政策。
Stanford Law Rev. 2006 Feb;58(4):1221-50.
6
Striking the right balance between innovation and drug price competition: putting the Hatch-Waxman Act into perspective.
Food Drug Law J. 1999;54(2):185-6.
7
8
The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?《北美自由贸易协定》对药品专利的影响：是难以下咽的苦药还是治疗良方？
J Contemp Health Law Policy. 1996 Spring;12(2):607-36.
9
The Dunkel draft--a prescription for disaster.邓克尔草案——一份灾难处方。
Natl Med J India. 1992 Jul-Aug;5(4):153-4.
10
Surviving the blockbuster syndrome.挺过轰动一时的综合征。
Science. 2004 Mar 19;303(5665):1796-9. doi: 10.1126/science.303.5665.1796.
Zotero 插件